S. van der Heide
University Medical Center Groningen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by S. van der Heide.
Clinical & Experimental Allergy | 2006
Ml Brouwer; Saa Wolt-Plompen; Anthony Dubois; S. van der Heide; Desiree Jansen; Ma Hoijer; Henk F. Kauffman; E. J. Duiverman
Background Studies have been performed suggesting that administration of probiotics may have therapeutic and/or preventive benefits in the development of sensitization and atopic disease, particularly in infants with atopic dermatitis (AD).
European Respiratory Journal | 1997
S. van der Heide; Hf Kauffman; A. E. J. Dubois; J. G. R. De Monchy
Recommendations for allergen avoidance or allergen reduction measures play an important part in the treatment of allergic asthmatic patients. The purpose of this study was to test recently developed air-cleaners with respect to their capacity to capture airborne allergen particles and to improve clinical parameters of asthmatic patients sensitized to aeroallergens. Forty five allergic asthmatic patients were studied in a double-blind procedure for 6 months. The patients were divided into three groups of 15 patients. In Group 1, the intervention consisted of the application of active air-cleaners in living-rooms and bedrooms. In Group 2, placebo air-cleaners were used in combination with allergen-impermeable mattress covers. In Group 3, the same intervention was performed as in Group 2 but with active air-cleaners. Allergen levels in mattress and floor dust were measured before, and 3 and 6 months after the interventions. After 6 months, the air-cleaners were dismantled and the filters were analysed for the amount of dust collected and allergen content. Immunological and lung function parameters were measured before, and 3 and 6 months after the interventions. Considerable amounts of airborne dust and allergenic particles were captured in the filters of the air-cleaners. Up to the 18.9 g of dust, 4,513 ng of house dust mite allergen, Der p 1, and 50,000 mU of cat allergen, Fel d 1, (in houses with cats) were collected by air-cleaners in living-rooms. Only in Group 3 (in which both active air-cleaners and mattress covers were used) was a small (less than 1 doubling dose) but statistically significant improvement of provocative concentration of histamine causing a 20% fall in forced expiratory volume in one second (PC20) observed (from 5.96 to 9.02 mg x mL(-1)). The amount of dust and house dust mite allergen collected in the filters was significantly correlated with an improvement of peak flow variation. In combination with other allergen avoidance measures, the examined air-cleaners can contribute to diminished allergen exposure and improvement of airway hyperresponsiveness in asthmatic patients.
Allergy | 2007
B. J. Vlieg-Boerstra; S. van der Heide; C. M. A. Bijleveld; J. Kukler; E. J. Duiverman; Anthony Dubois
Background: A cardinal feature of the double‐blind, placebo‐controlled food challenge (DBPCFC) is that placebo administration is included as a control. To date, the occurrence and diagnostic significance of placebo events have not extensively been documented.
Clinical & Experimental Allergy | 1999
S.G.M. Cloosterman; Tjard Schermer; I.D. Bijl-Hofland; S. van der Heide; Bert Brunekreef; F.J.J. van den Elshout; C.L.A. van Herwaarden; C.P. van Schayck
Exposure to house dust mite (HDM) allergens often results in worsening of asthma. Therefore, avoidance of exposure to HDM allergens is often proposed. Unfortunately, the most effective and feasible avoidance strategy is still not completely assessed. Consequently, we investigated the effects of a combined HDM avoidance strategy on HDM allergen concentrations and clinical condition of allergic, mild asthmatic, patients using no inhaled steroids.
Clinical & Experimental Allergy | 1997
S. van der Heide; J. G. R. De Monchy; K. de Vries; A. E. J. Dubois; Hf Kauffman
Background The degree of airway hyperresponsiveness in allergic asthmatic patients may be influenced by changes in environmental exposure to inhalant allergens.
Allergy | 2012
J.J. van Doormaal; E. van der Veer; P. C. van Voorst Vader; Philippus Kluin; André B. Mulder; S. van der Heide; Suzanne Arends; Johanna Kluin-Nelemans; J. N. G. Oude Elberink; J. G. R. De Monchy
Risk indicators of indolent systemic mastocytosis (ISM) in adults with clinical suspicion of ISM without accompanying skin lesions [urticaria pigmentosa (UP)] are lacking. This study aimed at creating a decision tree using clinical characteristics, serum tryptase, and the urinary histamine metabolites methylimidazole acetic acid (MIMA) and methylhistamine (MH) to select patients for bone marrow investigations to diagnose ISM.
Allergy | 2011
B. J. Vlieg-Boerstra; I. Herpertz; L. Pasker; S. van der Heide; J. Kukler; C. Jansink; W. Vaessen; B.J. Beusekamp; Anthony Dubois
To cite this article: Vlieg‐Boerstra BJ, Herpertz I, Pasker L, van der Heide S, Kukler J, Jansink C, Vaessen W, Beusekamp BJ, Dubois AEJ. Validation of novel recipes for double‐blind, placebo‐controlled food challenges in children and adults. Allergy 2011; 66: 948–954.
Clinical & Experimental Allergy | 2009
J. N. G. Oude Elberink; S. van der Heide; Gordon H. Guyatt; Anthony Dubois
Background In many European centers insect venom allergic patients with a reaction confined to the skin are only offered an epinephrine auto‐injector and not venom immunotherapy (VIT). Previously we showed that VIT improves health‐related quality of life (HRQL) of yellow jacket allergic patients with more than dermal reactions.
Allergy | 2011
B. J. Vlieg-Boerstra; W.E. van de Weg; S. van der Heide; Marjan Kerkhof; Paul Arens; G. Heijerman-Peppelman; Anthony Dubois
To cite this article: Vlieg‐Boerstra BJ, van de Weg WE, van der Heide S, Kerkhof M, Arens P, Heijerman‐Peppelman G, Dubois AEJ. Identification of low allergenic apple cultivars using skin prick tests and oral food challenges. Allergy 2011; 66: 491–498.
Contact Dermatitis | 2006
A. J. Hogen Esch; S. van der Heide; W. van den Brink; J.M. van Ree; Derk P. Bruynzeel; Pieter Jan Coenraads
After the start of heroin (diacetylmorphine)‐assisted treatment to a selected group of chronic treatment‐resistant heroin‐dependent patients in the Netherlands, we reported about work‐related eczema and positive patch tests to heroin in some nurses and nasal and respiratory complaints. To investigate the prevalence of heroin contact allergy, we started a questionnaire‐based study with follow‐up by allergological examinations. Of 120 questionnaires sent, 101 (84%) was returned: 67 from nurses and 34 from other employees. Of 101 workers, 38 (38%) had reported work‐related complaints: 33 of 67 (49%) nurses and 5 of 34 (15%) other employees. Patch tests to heroin were performed in 24 nurses and were positive in 8 (33%). All the 8 had eyelid or facial eczema and, in 6, accompanied by mucosal or respiratory complaints. The prevalence of heroin contact allergy in this study was 8% (8/101) among all employees and 12% (8/67) among nurses. Respiratory and mucosal complaints could not be ascribed to a contact allergy, and in these cases, serum was analysed for specific immunoglobulin E to heroin. A type 1 allergy to heroin could not be shown. These complaints are possibly due to the histamine‐liberating effect of heroin, to atopic constitution, to a combination of these factors or – less likely – to other non‐allergic factors.